| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10285), 1637-1645, 2021 | 453* | 2021 |
| Reward pays the cost of noise reduction in motor and cognitive control SG Manohar, TTJ Chong, MAJ Apps, A Batla, M Stamelou, PR Jarman, ... Current Biology 25 (13), 1707-1716, 2015 | 239 | 2015 |
| Parkinson’s disease in GTP cyclohydrolase 1 mutation carriers NE Mencacci, IU Isaias, MM Reich, C Ganos, V Plagnol, JM Polke, J Bras, ... Brain 137 (9), 2480-2492, 2014 | 179 | 2014 |
| Current opinions and areas of consensus on the role of the cerebellum in dystonia VG Shakkottai, A Batla, K Bhatia, WT Dauer, C Dresel, M Niethammer, ... The Cerebellum 16 (2), 577-594, 2017 | 154 | 2017 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial E Abaleke, M Abbas, S Abbasi, A Abbott, A Abdelaziz, S Abdelbadiee, ... The Lancet 397 (10274), 605-612, 2021 | 120 | 2021 |
| Multidisciplinary treatment for functional neurological symptoms: a prospective study B Demartini, A Batla, P Petrochilos, L Fisher, MJ Edwards, E Joyce Journal of Neurology 261 (12), 2370-2377, 2014 | 92 | 2014 |
| The phenotypic spectrum of DYT24 due to ANO3 mutations M Stamelou, G Charlesworth, C Cordivari, SA Schneider, G Kägi, ... Movement Disorders 29 (7), 928-934, 2014 | 92 | 2014 |
| Rest and other types of tremor in adult-onset primary dystonia R Erro, I Rubio-Agusti, TA Saifee, C Cordivari, C Ganos, A Batla, ... Journal of Neurology, Neurosurgery & Psychiatry 85 (9), 965-968, 2014 | 90 | 2014 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10325), 665-676, 2022 | 84 | 2022 |
| Psychogenic paroxysmal movement disorders–clinical features and diagnostic clues C Ganos, M Aguirregomozcorta, A Batla, M Stamelou, P Schwingenschuh, ... Parkinsonism & Related Disorders 20 (1), 41-46, 2014 | 81 | 2014 |
| Patients with scans without evidence of dopaminergic deficit: a long‐term follow‐up study A Batla, R Erro, M Stamelou, SA Schneider, P Schwingenschuh, C Ganos, ... Movement Disorders 29 (14), 1820-1825, 2014 | 73 | 2014 |
| Deconstructing Fahr's disease/syndrome of brain calcification in the era of new genes A Batla, XY Tai, L Schottlaender, R Erro, B Balint, KP Bhatia Parkinsonism & Related Disorders 37, 1-10, 2017 | 69 | 2017 |
| Differential diagnosis of parkinsonian syndromes using F-18 fluorodeoxyglucose positron emission tomography M Tripathi, V Dhawan, S Peng, S Kushwaha, A Batla, A Jaimini, ... Neuroradiology 55 (4), 483-492, 2013 | 68 | 2013 |
| Network localization of cervical dystonia based on causal brain lesions DT Corp, J Joutsa, RR Darby, CCS Delnooz, BPC van de Warrenburg, ... Brain 142 (6), 1660-1674, 2019 | 60 | 2019 |
| The long-term outcome of orthostatic tremor C Ganos, L Maugest, E Apartis, C Gasca-Salas, MT Cáceres-Redondo, ... Journal of Neurology, Neurosurgery & Psychiatry 87 (2), 167-172, 2016 | 47 | 2016 |
| The role of cerebellum in patients with late onset cervical/segmental dystonia?–evidence from the clinic A Batla, MC Sánchez, R Erro, C Ganos, M Stamelou, B Balint, F Brugger, ... Parkinsonism & related disorders 21 (11), 1317-1322, 2015 | 47 | 2015 |
| H‐ABC syndrome and DYT4: variable expressivity or pleiotropy of TUBB4 mutations? R Erro, J Hersheson, C Ganos, NE Mencacci, M Stamelou, A Batla, ... Movement Disorders 30 (6), 828-833, 2015 | 44 | 2015 |
| Myoclonus-dystonia syndrome due to tyrosine hydroxylase deficiency M Stamelou, NE Mencacci, C Cordivari, A Batla, NW Wood, H Houlden, ... Neurology 79 (5), 435-441, 2012 | 44 | 2012 |
| Functional movement disorders are not uncommon in the elderly A Batla, M Stamelou, MJ Edwards, I Pareés, TA Saifee, Z Fox, KP Bhatia Movement Disorders 28 (4), 540-543, 2013 | 41 | 2013 |
| Dystonic opisthotonus: a “red flag” for neurodegeneration with brain iron accumulation syndromes? M Stamelou, SC Lai, A Aggarwal, SA Schneider, H Houlden, TH Yeh, ... Movement Disorders 28 (10), 1325-1329, 2013 | 40 | 2013 |
Kailash BhatiaProfessor of Clinical Neurology, Institute of Neurology, UCL, Queen Square, London WC1N 3BG,Verified email at ucl.ac.uk
